A study to observe real-life allocation of antipsychotics in acute inpatient management of schizophrenia - RECONNECT-S

Study identifier:NIS-NRU-ATC-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

RECONNECT-S ALPHA: A non-interventional study to observe real-life allocation of antipsychotics in the acute inpatient management of schizophrenia

Medical condition

schizophrenia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

600

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Aug 2011
Primary Completion Date: 01 Dec 2011
Study Completion Date: 01 Dec 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria